Connect with us
Eli Lilly is investing $5.3 billion in a new Indiana plant to increase production of diabetes and weight loss drugs, raising total facility investment to $9...
Merck is acquiring Mirus Bio for $600 million to accelerate growth in revolutionary technologies. CEO Belén Garijo aims to make cell and gene therapies accessible globally....
BaseLaunch, a Basel biotech incubator, gains support from AbbVie, joining Roche, Novo Nordisk, Johnson & Johnson, and CSL Behring. Operated by Basel Area Business & Innovation,...
AstraZeneca aims to nearly double its 2023 sales to $80 billion by 2030, focusing on cancer and rare disease treatments. CEO Pascal Soriot highlighted twelve potential...
Esteve reported a 10% growth in 2023, with net income of €710 million. Revenue grew 2% in Spain, 18% in the EU, and 9% globally, especially...
Until now, in the field of anti-obesity treatments, there was a drug that attracted attention: Ozempic. It is also made by Novo Nordisk and is very...
Goldman Sachs increased its stake in Grifols from 5.8% to 6.4%, amid a bearish attack by Gotham City Research, coinciding with Grifols' Q1 results. Melqart reduced...
In 2023, Spanish biotech companies secured 228 million euros in private financing, a 37% increase from 2022. This was announced at the AseBio Investor Day, organized...
BioNTech saw a sharp drop in profits, starting 2024 with a €315 million loss, down from a €502 million profit the previous year, and sales plummeting...
Sanofi acquires 4.9% of Novavax shares for $70 million, doubling the latter's valuation to around $1.4 billion. This investment is part of a co-exclusive licensing agreement...
 |
|
 |  |
 |
|